The Cons of Patenting Genes. What someone can “own” is a DNA sequence that he or she was the first to isolate and that is useful. 3. The often-cited case of Madey v. Duke University (307 F.3d 1351 (Fed. The article reports the results of a telephone survey of 211 directors of laboratories that do molecular diagnostic testing. Third Wave’s 10-K for 2005, the latest available, states that it spent $8.4 million for R&D for that year. Finally, the invention must be clearly claimed so that the public knows the scope of the limited property right. Podcast: Elections, Covid & The Great Reset, ‘We Will Get Through This’ How to Resist Govt. Thus, a patent is a limited property right. By being able to patent a gene, a company could look at those genes without competition or worry and this could allow for more new discoveries because there isn’t such a rush to find profits. Gene patents fall under intellectual property rights. As with any human activity, even one as important as scientific research, there have to be limits. 2. The invention must not be obvious; that is, the novelty should not be a trivial one that any person of routine skill in the technology could have envisioned. The public is protected because the patent statute permits no more than the actual contribution made by the inventor to be the subject of the limited property right. These principles have supported the patent system for over 200 years and have contributed to the technological greatness of this nation and to the benefits that technology brings to humankind. It is the usual suspects—nobody should own our genes because they exist in nature, and gene patents are bad public policy because they suppress research and hurt patient care. It is also not a monopoly, even though the right extends to a class of things, because a monopoly is defined by market power. Academic researchers believe that scientific advancement occurs through the publication of research results. Gene patenting has its pros and its cons. Protects an item’s way of operating (or how it works) 2. Debatabase. The Cons of Gene Patenting 1. Companies need to make money. Various academics have been leading the charge, closely followed by groups that perceive their professional interests to be threatened. In a perfect world, medical science wouldn’t have any profit or loss factor to it. 3. Gene patenting is one of several biotech hot-button issues that run through the novel. Critics have also charged that patents raise costs to patients and/or limit patient access to medical care. Similarly, a person who discovers a new function of a known DNA sequence, such as its previously unknown association with particular disease, can patent a method of using the isolated sequence to detect susceptibility to that disease. Advantages of Patents. What it gets for free is the new technical knowledge to build on because the patent must disclose how to make and how to use the invention in terms that a person skilled in that technology can understand. It could lead to monopolies. Patents can give intellectual property rights for up to 20 years in some cases, which would mean that research could potentially be stopped in certain areas. In the future, such molecules will be commonplace, but at the The university had forced Madey out of his position as a laboratory director, and he responded with a powerful weapon that he had at hand—a patent-infringement suit. Gene patents, more specifically patent claims to nucleotide sequences, such as genes, plasmids, and probes, are fundamental and critical to the biotech industry. April 14, 2009: "In those twenty years of a patent’s duration, any prospective research is carried out in fear of recriminations and law-suits from the patent-holder. If you have 10 people studying something instead of one person, … Why should new technology be free? Patenting genes that are discovered would be like creating a patent... 2. CTRL + SPACE for auto-complete. One of the respondents even acknowledged this by stating, “People shouldn’t be complaining that they can’t run tests. The vast majority of patent owners simply do not want the adverse publicity of suing scientists and their universities, and the economic recovery is seldom worth the effort and money spent. As a practical matter, however, academic scientists who ignore patent rights have little to fear. They are the foundation of the industry. But that is not to say that the issue is trivial, just that it cannot be dealt with at the level of patent claims. Since isolated DNA sequences do not occur in nature, they are not natural products. Gene patenting invites malicious lawsuits from patent-holders Gene Patenting. There would be the option for personal investment into research and development. Quite simply, this investment will not happen if, after it is done, a competitor can get a free ride on the pioneer’s efforts and knock-off the product. E-mail: geoff.karny@bakerd.com. Forced Vaccinations Are Being Proposed! How About Shutting Down the CDC, FDA, and other ‘Public Health’ Agencies? Cognition Thinks It Has an Alzheimer’s Blockbuster, T Cells with Upgraded Molecular Computers Can Sort Out Tumor Targets, Dexamethasone May Be Detrimental to Immunotherapy in Glioblastoma Patients, Post-Myocardial Infarction Treatment Shows Promise in Mice, Robotic Culture System Enables Mechanistic View of How Bacteria Evolve Drug…, Steering Stem Cells to Repair Sites Using Inflammo-Free Inflammo-Attraction, Multi-Attribute Methods Supporting Quality Assessments of Therapeutic Proteins, COVID Driving Biopharma to Embrace Digital Tech Faster, Boosting Capabilities in Gene and Cell Therapy Bioprocessing, Bioprocessing’s Potential Impact on Patients, Top 10 Earners among Women Biopharma Executives, In Praise of Lesser-Sung Life Sciences Clusters, Blinking Red: 25 Missed Pandemic Warning Signs, Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development, An Autologous Stem Cell-Based Therapy for Parkinson’s Disease, With Synthetic Biology Nature Is All Business, Biobanks Are Becoming Data Banks in the Era of Personalized Medicine, Cryopreservation to Improve Cell Manufacturing and Biobanking, Enabling Scientific Discovery and Healthcare with Biobanks, Bavarian Nordic Obtains License to Vivalis’ ESC-derived Cell Lines, COVID-19 Drug & Vaccine Candidate Tracker, Lipocalin-2 Could Be Used as Potential Treatment for Obesity, Fruit and Cocoa Flavanols Improve Mental Agility in Human Study, Tarantula Toxins Provide Insights to Treating Chronic Pain, Varied Cell Signals Recorded at Once with Spatial Multiplexing.